Reference 2018-20

REF:            2018-20   

Subject:        Wet Age Related Macular   

 

 

Request:

Within your trust how many patients have been treated, in the past 6 months July to December 2017 by diagnosed eye condition. Of these patients how many are new to treatment [they have not previously received an injection / implant]?

 

 

 

Response:

We are unable to provide figures by disease state only total numbers for each drug.

Below are the total number for Lucentis and Eylea.

Total Total Patients Lucentis (ranibizumab) Patients Eylea (aflibercept) Patients
983 490 493